Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

InKine seeks FDA approval of Diacol

Nov. 24, 1999

Agents for ulcers and other GI disorders under study at AstraZeneca

Nov. 24, 1999

PEG-Intron submitted for marketing approval in Europe

Nov. 22, 1999

XTL and Roche to evaluate HCV therapeutics

Nov. 19, 1999

Oral bioavailability of AM-188 markedly improved by prodrugs: preclinical studies

Nov. 19, 1999

Entecavir: absorption, distribution, metabolism and excretion assessed in preclinical studies

Nov. 18, 1999

Dihydropyrimidines for hepatitis B designed at Bayer

Nov. 18, 1999

DGT and Immunex renew IBD collaboration

Nov. 18, 1999

Effects of IL-10 agonist IT-9302 on immunological markers in acute necrotizing pancreatitis

Nov. 17, 1999

Hoe-140 effective against joint but not intestinal inflammation in rat model

Nov. 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...